Lifeboat Foundation

The International Society on Aging and Disease (ISOAD) recently held its third international conference in Nice, France, bringing together researchers – and longevity activists – from around the world. Journalist and supporter of anti-aging research Oliver Rowland attended the event and has made this great report packed with information gathered from interviews and talks at the event.

Professor Eric Gilson

After working in Lyon, Prof. Gilson founded the Ircan Institute for Research on Cancer and Aging in Nice in 2012. “It was perhaps the first institute that specifically aimed to couple the themes of aging and cancer in the same laboratory, even if the links between them had been known to some extent,” he said. “That was its originality.”

A new study by Calico found that our genes determine our lifespan much less than previously accepted and lifespan heritability is less than seven percent.

Although long life tends to run in families, genetics has far less influence on life span than previously thought, according to a new analysis of an aggregated set of family trees of more than 400 million people. The results suggest that the heritability of life span is well below past estimates, which failed to account for our tendency to select partners with similar traits to our own. The research, from Calico Life Sciences and Ancestry, was published in Genetics.

“We can potentially learn many things about the biology of aging from human genetics, but if the heritability of life span is low, it tempers our expectations about what types of things we can learn and how easy it will be,” says lead author Graham Ruby. “It helps contextualize the questions that scientists studying aging can effectively ask.”

Continue reading “Family tree of 400 million people shows genetics has limited influence on longevity” »

As part of our strategy, we are constantly networking and seeking opportunities to engage new audiences about the topic of healthy life extension. Recently our President, Keith Comito appeared on the Young Turks Rebel HQ and spoke with Cenk Uygur, the host, and creator of the Young Turks.

The Young Turks is an American progressive political and social commentary channel that covers news and current affairs. Cenk Kadir Uygur is a Turkish-American businessman, columnist, journalist, activist, and political commentator.

The NAD+ Mouse Project has ended in a record-breaking amount raised for a research project so far on Lifespan.io. The campaign ended yesterday after having raised a total of $75,285 and smashing three stretch goals!.

An amazing 321 people backed the campaign and they will get to enjoy a range of great donor rewards and know that they have been a part of launching a great experiment. Thanks to their help the researchers will now be able to test if NMN has potential as an anti-aging drug.

We are both humbled and so very grateful for the generous support of the NAD mouse project. As the excitement and potential of the NAD longevity field continues to grow, we can’t wait to see what we learn and report to our supporters about what NMN can do. – Dr. David Sinclair

Continue reading “NAD+ Mouse Project a Record Breaker” »

Rutgers scientists have created a tiny, biodegradable scaffold to transplant stem cells and deliver drugs, which may help treat Alzheimer’s and Parkinson’s diseases, aging brain degeneration, spinal cord injuries and traumatic brain injuries.

Stem cell transplantation, which shows promise as a treatment for central nervous system diseases, has been hampered by low cell survival rates, incomplete differentiation of cells and limited growth of neural connections.

So, Rutgers scientists designed bio-scaffolds that mimic natural tissue and got good results in test tubes and mice, according to a study in Nature Communications. These nano-size scaffolds hold promise for advanced stem cell transplantation and neural tissue engineering. Stem cell therapy leads to stem cells becoming neurons and can restore neural circuits.

Active discussion on tne most effective technologies in comments to this page post. Number one is blood plasma-derived therapy.

Money has been pouring into startups researching longevity as treatments for aging become more of a reality. Here are the venture funds and pharma companies placing bets.

Isaac does good work. This is no exception.

LEAF President Keith Comito on the channel TYT talking about healthy life extension! smile

If we can reach our third and final stretch goal and expand the scope of the experiment massively. Could NMN be a true anti-aging drug?

Sp S on S so S red S.

Continue reading “The last 15 hours of the NAD+ Mouse fundraiser and we are only $2431 away from the final goal” »